NCT03055234View on ClinicalTrials.gov

Study to Evaluate Efficacy and Safety of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Sickle Cell Disease (SCD)

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2017

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2022

Conditions
Pulmonary Hypertension Associated With Sickle Cell Disease
Interventions
DRUG

Oral Treprostinil

Extended-release oral tablet for TID administration

DRUG

Placebo

Matching placebo for TID administration

Sponsors
All Listed Sponsors
lead

United Therapeutics

INDUSTRY